THE GLOBE AND MAIL FEATURES DATAMETREX AS ONE OF THE TOP MENTAL HEALTH COMPANIES

Toronto, Canada, August 4, 2022 – Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce that it has been recognized as one of the Top Mental Health Companies Battling the Suicide Epidemic.

“Mental health is on the decline all over the world. In fact, according to Morning Call, Given the challenges of the last two years, it’s not surprising we find ourselves in a national mental health crisis. According to the Centers for Disease Control and Prevention, cases of depression and anxiety were four times higher during the first year of the pandemic compared to previous years. Nationally, the proportion of mental health-related emergency department visits among adolescents aged 12-17 years increased 31% compared to pre-pandemic numbers. In the U.S., one person dies by suicide every 11 minutes. The good news is more companies are lining up to help, including Datametrex AI Limited (TSXV: DM) (OTCQB: DTMXF).”

Read the feature here: https://www.theglobeandmail.com/investing/markets/stocks/DM-X/pressreleases/9470671/these-top-mental-health-companies-are-battling-the-suicide-epidemic/

About Medi-Call

Medi-call is a subscription-based software as a service (SaaS) mobile application that connects patients with doctors. It is an integrated grid system that connects patients with providers in real time. Medi-Call solves accessibility issues for patients living in rural or isolated communities and those also have limited mobility while improving coordination and communication of treatment among healthcare team members and their patients. Medi-Call facilitates mobile health care services, including prescriptions and is passionate about building doctor-patient relationships virtually.

Visit Medicallmd.ca to learn more about the Company.

Download the Medi-Call App for Android: https://bit.ly/MCGooglePlay

Download the Medi-Call App for iOS: https://apple.co/3oos9m2

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, machine learning, telehealth and has recently entered the electric vehicle (EV) market. Datametrex’ mission is to provide tools and solutions that support companies in fulfilling their operational goals, including health and safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through artificial intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.

For further information:

Investor Relations & Communications

Priya Monique Atwal, Director of Communications

Email: investors@datametrex.com

Tel: 416-901-5611 x 204

Marshall Gunter, CEO

Email: mgunter@datametrex.com

Tel: 514-295-2300

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements, including statements regarding the Bid. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

###